LBA15Preliminary results of the first-in-human (FIH) study of MK-1454, an agonist of stimulator of interferon genes (STING), as monotherapy or in combination with pembrolizumab (pembro) in patients with advanced solid tumors or lymphomas
Harrington, K J, Brody, J, Ingham, M, Strauss, J, Cemerski, S, Wang, M, Tse, A, Khilnani, A, Marabelle, A, Golan, TVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy424.015
Date:
October, 2018
File:
PDF, 97 KB
2018